Literature DB >> 35450364

SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity.

Matthew L Hammill1, Kouta Tsubaki1,2, Lidya Salim1, Andrew J Varley1, Ifrodet Giorgees1, Mitsuru Kitamura2, Tatsuo Okauchi2, Jean-Paul Desaulniers1.   

Abstract

Short interfering RNAs (siRNAs) show promise as gene-silencing therapeutics, but their cellular uptake remains a challenge. We have recently shown the synthesis of siRNAs bearing a single neutral phenylethyl phosphotriester linkage within the sense strand. Here, we report the synthesis of siRNAs bearing three different hydrophobic phosphate triester linkages at key positions within the sense strand and assess their gene silencing in the absence of a transfection carrier. The best siRNAs bearing hydrophobic phosphate triester tails were not aromatic and exhibited effective gene silencing (IC50 ≈ 56-141 nM), whereas the aromatic derivative with three hydrophobic tails did not exhibit carrier-free gene silencing.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35450364      PMCID: PMC9014433          DOI: 10.1021/acsmedchemlett.2c00027

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  30 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

2.  RNA interference in mammalian cells by chemically-modified RNA.

Authors:  Dwaine A Braasch; Susan Jensen; Yinghui Liu; Kiran Kaur; Khalil Arar; Michael A White; David R Corey
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

3.  Selective Transesterification of 2,2,2-Trifluoroethyl Phosphates: Synthesis of Mixed Unsymmetrical Phosphates.

Authors:  Kouta Tsubaki; Hirokazu Shimooka; Mitsuru Kitamura; Tatsuo Okauchi
Journal:  Org Lett       Date:  2019-11-25       Impact factor: 6.005

Review 4.  Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.

Authors:  Siddharth Shukla; Chintan S Sumaria; P I Pradeepkumar
Journal:  ChemMedChem       Date:  2010-03-01       Impact factor: 3.466

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 6.  The current state and future directions of RNAi-based therapeutics.

Authors:  Ryan L Setten; John J Rossi; Si-Ping Han
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

7.  Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.

Authors:  Jayaprakash K Nair; Jennifer L S Willoughby; Amy Chan; Klaus Charisse; Md Rowshon Alam; Qianfan Wang; Menno Hoekstra; Pachamuthu Kandasamy; Alexander V Kel'in; Stuart Milstein; Nate Taneja; Jonathan O'Shea; Sarfraz Shaikh; Ligang Zhang; Ronald J van der Sluis; Michael E Jung; Akin Akinc; Renta Hutabarat; Satya Kuchimanchi; Kevin Fitzgerald; Tracy Zimmermann; Theo J C van Berkel; Martin A Maier; Kallanthottathil G Rajeev; Muthiah Manoharan
Journal:  J Am Chem Soc       Date:  2014-12-01       Impact factor: 15.419

8.  Multiple sensors ensure guide strand selection in human RNAi pathways.

Authors:  Cameron L Noland; Jennifer A Doudna
Journal:  RNA       Date:  2013-03-26       Impact factor: 4.942

9.  Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.

Authors:  Sander F Garrelfs; Yaacov Frishberg; Sally A Hulton; Michael J Koren; William D O'Riordan; Pierre Cochat; Georges Deschênes; Hadas Shasha-Lavsky; Jeffrey M Saland; William G Van't Hoff; Daniel G Fuster; Daniella Magen; Shabbir H Moochhala; Gesa Schalk; Eva Simkova; Jaap W Groothoff; David J Sas; Kristin A Meliambro; Jiandong Lu; Marianne T Sweetser; Pushkal P Garg; Akshay K Vaishnaw; John M Gansner; Tracy L McGregor; John C Lieske
Journal:  N Engl J Med       Date:  2021-04-01       Impact factor: 91.245

Review 10.  Therapeutic siRNA: principles, challenges, and strategies.

Authors:  Kseniya Gavrilov; W Mark Saltzman
Journal:  Yale J Biol Med       Date:  2012-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.